Most Americans Say Drug Costs Are ‘Unreasonable,’ Although They Can Still Afford To Buy Them

Nearly three in four Americans say the costs of prescription drugs are “unreasonable” — and most blame drugmakers for those prices, according to a poll released Tuesday.

The survey by the Kaiser Family Foundation found 74 percent of those taking prescription drugs find the costs unreasonable, as do 72 percent of those not taking such drugs. (KHN is an editorially independent program of the foundation.)

The poll builds on the results of an earlier Kaiser survey in April that identified high drug costs as the public’s top health care priority for Congress and the president. Drug costs have gained attention in the past year in part as a result of controversies surrounding Sovaldi and other new hepatitis C drugs, which can cure most cases of the deadly liver disease but at a price of $84,000 for a 12-week treatment. The high cost has strained Medicaid and Medicare budgets and left private insurers scrambling.

Half the public say they take prescription drugs. More than three quarters of those say they are easy to afford, with only one in five saying they have difficulty paying for them. But about a quarter of respondents said they or a family member have not filled a prescription in the past year, while 18 percent have cut pills in half or skipped doses to save money, the poll found.

More than three-quarters of the public cited drug company profits as the No. 1 reason for the high costs, followed by the expense of medical research (64 percent), the cost of marketing (54 percent) and the cost of lawsuits against pharmaceutical companies (49 percent).

About 10 percent of respondents also blame insurance companies, saying they require enrollees to shoulder too great a share of drug costs.

The survey also found most Americans are still not paying attention to the latest challenge to the Affordable Care Act in a case called King v. Burwell. The Supreme Court is expected to decide this month whether to cut off government subsidies to millions of people in about three dozen states that rely on a federal insurance marketplace, rather than a state-based marketplace. About 72 percent of respondents say they have heard little or nothing about the case.

However, the survey found more than half of respondents were “very” or fairly closely” following news about the 2016 presidential campaign. About 39 percent of respondents said they were closely following news about the House of Representatives banning abortions after 20 weeks of pregnancy — the most closely followed health policy issue.

The poll of 1,200 adults, conducted from June 2 to June 9, had a margin of error of plus or minus 3 percentage points.

Source Link

Recommended Articles

White House Leaves One Trump-Era Policy Alone

The Biden administration has gutted many of former President Donald Trump’s health care policies, but there’s one that the White House has yet to touch, Kelly reports. It’s a 2019 rule that expanded individual coverage health reimbursement arrangements, or ICHRAs, which allowed employers to provide tax-exempt subsidies to help workers purchase Obamacare plans. The Biden administration’s ...

Read More

Court Strikes Down HHS Rule that Allowed Insurers to Not Count Copay Assistance

In a major victory for patients who depend on prescription drugs, Judge John D. Bates of the U.S. District Court for the District of Columbia struck down a Trump administration federal rule that allowed health insurers to not count drug manufacturer copay assistance towards a beneficiary’s out-of-pocket costs. The case was brought against the U.S. Department of Health and ...

Read More

Lawmakers, Payers And Providers All Air Grievances With Federal No Surprises Act Implementation

Amid a flurry of partisan roadblocks rolling out across Capitol Hill, representatives on both sides of the aisle came together Tuesday to critique federal agencies’ rollout of the No Surprises Act and throw their support behind court-ordered rewrites of independent dispute resolution (IDR) regulations. During a hearing exploring the “flawed implementation” of the law intended ...

Read More

As Biden Plans To Ban Medical Debt From Credit Scores, Advocates Press For More Change

The dramatic impact of medical debt on credit scores may soon be a thing of the past. On Thursday, the White House announced a plan outlined by the Consumer Financial Protection Bureau (CFPB) to eliminate medical debt from credit reports. The move — which follows an earlier decision from the three main credit bureaus to eliminate paid medical debt, medical ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square